Wide reagent range for COVID-19 assay development

ECB, LeeBio, Medix Biochemica covid-10 products

Together EastCoast Bio, Lee Biosolutions and Medix Biochemica offer a wide range of critical reagents for COVID-19 assay development. Products from each portfolio include:

EastCoast Bio:

  • Anti-SARS-CoV-2 Nucleocapsid monoclonal antibodies – NEW
  • Anti-SARS-CoV-2 Spike 1 protein monoclonal antibodies – NEW
  • Recombinant SARS-CoV-2 Spike 1 and Nucleocapsid antigens

Lee Biosolutions:

  • COVID-19 cross-reactivity serum/plasma panel – NEW
  • COVID-19 confirmed positive & negative serum/plasma samples
  • COVID-19 confirmed positive & negative nasopharyngeal swabs
  • Nasal fluid and sputum samples collected prior to November 2019

Medix Biochemica:

Please do not hesitate to contact us for more information.